Defitelio (Defibrotide Sodium Vials) 200mg/2.5ml (80mg/ml)

Defitelio (Defibrotide Sodium) is an injectable medication used to support liver and kidney function in certain medical conditions. It comes in 200mg/2.5ml vials for intravenous use. This product is stored at room temperature and is commonly used in hospital settings.

Strength

200mg/2.5ml (80mg/ml)

Pack Size

10s

Storage

Ambient

Manufacturer / TM Owner

Patheon Italia S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Defitelio is primarily used to help manage conditions where blood clots form in small blood vessels, which can affect the liver and kidneys. It is often prescribed to support patients undergoing certain treatments that may impact blood flow. This medication is also used to prevent complications in patients receiving stem cell transplants.

Side Effects

Defitelio works by helping to maintain normal blood flow in the body, particularly in the liver and kidneys. It supports the function of these organs by reducing the risk of blockages in small blood vessels. Patients may notice improved organ function as a result of its use.

Precautions & Warnings

Defitelio should be handled with care and administered by healthcare professionals. It is important to store the vials at room temperature and protect them from light. Patients should inform their healthcare provider about any allergies or other medications they are taking before using this product.

Avoid Interactions

Defitelio may interact with other medications that affect blood clotting or blood pressure. It is important to avoid combining it with drugs that increase bleeding risk, such as anticoagulants or antiplatelets. Patients should consult their healthcare provider to ensure safe use alongside other treatments.

References

Frequently Asked Questions

Defitelio is used to support liver and kidney function in patients with conditions involving blood clots in small blood vessels.

Defitelio is given as an intravenous injection by a healthcare professional.

Yes, Defitelio vials should be stored at room temperature and protected from light.

Common side effects may include bleeding or low blood pressure, but these should be monitored by a healthcare provider.

Defitelio may interact with other drugs, so patients should inform their healthcare provider about all medications they are taking.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.